PE20190222A1 - Virus recombinante de la enfermedad de newcastle que expresa una proteina inmunomoduladora como adyuvante molecular - Google Patents
Virus recombinante de la enfermedad de newcastle que expresa una proteina inmunomoduladora como adyuvante molecularInfo
- Publication number
- PE20190222A1 PE20190222A1 PE2018001566A PE2018001566A PE20190222A1 PE 20190222 A1 PE20190222 A1 PE 20190222A1 PE 2018001566 A PE2018001566 A PE 2018001566A PE 2018001566 A PE2018001566 A PE 2018001566A PE 20190222 A1 PE20190222 A1 PE 20190222A1
- Authority
- PE
- Peru
- Prior art keywords
- newcastle disease
- recombinant virus
- post
- immunomodulating protein
- molecular adjuvant
- Prior art date
Links
- 230000002519 immonomodulatory effect Effects 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 241000700605 Viruses Species 0.000 title abstract 2
- 208000010359 Newcastle Disease Diseases 0.000 title 1
- 239000002671 adjuvant Substances 0.000 title 1
- 241000711404 Avian avulavirus 1 Species 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000036755 cellular response Effects 0.000 abstract 1
- 230000008348 humoral response Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 230000002103 transcriptional effect Effects 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
La invencion se refiere a Virus de la Enfermedad de Newcastle recombinantes (NDVr's), que llevan inserta una unidad transcripcional ajena a su genoma, la cual codifica para la sintesis de proteinas inmunomoduladoras. Estos sistemas ofrecen excelentes resultados de proteccion y disminuye significativamente la carga viral excretada (post-vacunacion y post-desafio) en aves inmunizadas varias semanas despues de ser desafiadas con una cepa velogenica del Virus de Newcastle. Adicionalmente, dichas vacunas permiten la proteccion de aves contra otros agentes patogenos durante un largo periodo de tiempo ya que inducen un aumento de los niveles de las proteinas inmunomoduladoras, lo que se traduce en una potenciacion de la respuesta inmune del hospedero y la promocion de una eficiente respuesta humoral y celular
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2016002399A MX2016002399A (es) | 2016-02-24 | 2016-02-24 | Virus recombinante de la enfermedad de newcastle que expresa una proteina inmunomoduladora como adyuvante molecular. |
PCT/IB2017/051053 WO2017145096A2 (es) | 2016-02-24 | 2017-02-24 | Virus recombinante de la enfermedad de newcastle que expresa una proteína inmunomoduladora como adyuvante molecular |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20190222A1 true PE20190222A1 (es) | 2019-02-13 |
Family
ID=59685995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2018001566A PE20190222A1 (es) | 2016-02-24 | 2017-02-24 | Virus recombinante de la enfermedad de newcastle que expresa una proteina inmunomoduladora como adyuvante molecular |
Country Status (6)
Country | Link |
---|---|
US (1) | US20190134188A1 (es) |
CN (1) | CN109195613A (es) |
CL (1) | CL2018002333A1 (es) |
MX (1) | MX2016002399A (es) |
PE (1) | PE20190222A1 (es) |
WO (1) | WO2017145096A2 (es) |
-
2016
- 2016-02-24 MX MX2016002399A patent/MX2016002399A/es unknown
-
2017
- 2017-02-24 WO PCT/IB2017/051053 patent/WO2017145096A2/es active Application Filing
- 2017-02-24 CN CN201780025360.9A patent/CN109195613A/zh active Pending
- 2017-02-24 US US16/079,975 patent/US20190134188A1/en not_active Abandoned
- 2017-02-24 PE PE2018001566A patent/PE20190222A1/es unknown
-
2018
- 2018-08-14 CL CL2018002333A patent/CL2018002333A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
US20190134188A1 (en) | 2019-05-09 |
WO2017145096A3 (es) | 2017-11-09 |
WO2017145096A2 (es) | 2017-08-31 |
CL2018002333A1 (es) | 2019-01-11 |
MX2016002399A (es) | 2017-08-23 |
CN109195613A (zh) | 2019-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2021000636A1 (es) | Vacuna contra el virus de la peste porcina africana | |
CO2018005229A2 (es) | Vacuna de virus sincitial respiratorio | |
CO2018005258A2 (es) | Vacuna del virus herpes simple | |
EA201891415A8 (ru) | Антигены вируса иммунодефицита человека, векторы, композиции и способы их применения | |
PE20141482A1 (es) | Vectores recombinantes de hvt que expresan antigenos de patogenos de aves y sus usos | |
AR102006A1 (es) | Vacunas recombinantes contra el virus de la fiebre aftosa (fmdv) y sus usos | |
CO2019011548A2 (es) | Vacunas contra el gallid herpesvirus 3 recombinante que codifican antígenos patogénicos aviares heterólogos | |
CO2017007105A2 (es) | Nuevos virus de tilapia | |
MX347997B (es) | Vacunas aviares vectorizadas con el virus de la enfermedad de newcastle. | |
BR112015005987A2 (pt) | vacina, métodos para induzir uma resposta imune contra um antígeno hbv, para proteção de um sujeito da infeção por hbv, para proteger o sujeito que foi diagnosticado com uma infecção por hbv, para induzir uma resposta imune contra um antígeno do hbv, para proteger um indivíduo da infecção pelo hbv, para proteger um indivíduo que foi diagnosticado com infecção pelo hbv, para proteger um indivíduo da infecção pelo hbv, para proteger um indivíduo que foi diagnosticado com infecção pelo hbv, para proteger um sujeito contra infecção por hbv e para proteger o sujeito que foi diagnosticado com uma infecção por hbv, molécula de ácido nucleico, e, proteína | |
MX344103B (es) | Vacunas de virus herpes vectorizado con virus de enfermedad de newcastle. | |
AR080313A1 (es) | Composiciones de virus de moquillo canino (cdv) recombinante y sus usos | |
AR094725A1 (es) | Parvovirus 5a porcino, métodos de uso y vacuna | |
AR081856A1 (es) | Vacuna y metodos para reducir una infeccion por campylobacter | |
RU2018127403A (ru) | Поливалентная вакцина против hyo и ее применение | |
PE20170429A1 (es) | Vacuna en vector recombinante de adenovirus aviar serotipo 9 | |
EA201500837A1 (ru) | Парвовирус свиней 5в, способы применения и вакцина | |
CL2008003845A1 (es) | Vacuna que comprende una emulsion, una bacterina tratada termicamente a 55-70°c por 5-10 horas, que comprende una suspension de bacterias muertas de la especie leptospira bratislava, y de 1 a 13 virus causantes de enfermedad porcina. | |
CO6700818A2 (es) | Vectores de parapoxvirus | |
BR112015023738A2 (pt) | vacinas de nucleoproteina influenza | |
WO2014140166A3 (en) | Vaccine | |
CO2018008184A2 (es) | Virus de vacuna del síndrome respiratorio y reproductivo porcino | |
PE20190222A1 (es) | Virus recombinante de la enfermedad de newcastle que expresa una proteina inmunomoduladora como adyuvante molecular | |
WO2001070932A3 (en) | Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife | |
ECSP14023407A (es) | Virus de la enfermedad de marek modificado y vacunas elaboradas con él |